Clinical Trials for AMN107

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCHEM1323
10/03/2013
A Phase II Randomized, Multicenter Study of Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Patients Who Achieve and Sustain MR4.5 After Switching to Nilotinib

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.